NKGen Biotech Management
Management criteria checks 1/4
NKGen Biotech's CEO is Paul Y. Song, appointed in Sep 2023, has a tenure of less than a year. total yearly compensation is $3.33M, comprised of 15% salary and 85% bonuses, including company stock and options. directly owns 0.66% of the company’s shares, worth $166.64K. The average tenure of the management team and the board of directors is 0.9 years and 0.9 years respectively.
Key information
Paul Y. Song
Chief executive officer
US$3.3m
Total compensation
| CEO salary percentage | 15.0% |
| CEO tenure | less than a year |
| CEO ownership | 0.7% |
| Management average tenure | less than a year |
| Board average tenure | less than a year |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$80m |
| Dec 31 2023 | US$3m | US$500k | -US$83m |
| Sep 30 2023 | n/a | n/a | -US$56m |
| Jun 30 2023 | n/a | n/a | -US$30m |
| Mar 31 2023 | n/a | n/a | -US$29m |
| Dec 31 2022 | US$37m | US$366k | -US$27m |
Compensation vs Market: Paul Y.'s total compensation ($USD3.33M) is above average for companies of similar size in the US market ($USD693.01K).
Compensation vs Earnings: Paul Y.'s compensation has been consistent with company performance over the past year.
CEO
Paul Y. Song (58 yo)
less than a year
Tenure
US$3,328,322
Compensation
Dr. Paul Y. Song, M.D. joined Calyx Peak Of Ma, Inc. as Chief Medical Officer in 2017. Dr. Song, a board-certified radiation oncologist in Los Angeles and a partnership was formed. He was a Co-Founder & Ch...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman | less than a year | US$3.33m | 0.66% $ 166.6k | |
| Chief Scientific Officer | less than a year | US$809.26k | 0.11% $ 27.8k | |
| Founder & Executive Director | less than a year | US$576.00k | 1.54% $ 388.8k | |
| Interim Chief Financial Officer | less than a year | no data | 9.48% $ 2.4m | |
| Chief Operating Officer | less than a year | no data | no data | |
| Vice President of Technical Operations | no data | no data | no data | |
| Vice President of Investor Relations & Corporate Communications | no data | no data | no data | |
| Vice President of Human Resources | no data | no data | no data | |
| SVP of Financial Planning & Analysis and Corporate Strategy | less than a year | no data | no data |
0.9yrs
Average Tenure
58yo
Average Age
Experienced Management: NKGN's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman | less than a year | US$3.33m | 0.66% $ 166.6k | |
| Founder & Executive Director | less than a year | US$576.00k | 1.54% $ 388.8k | |
| Independent Director | less than a year | no data | 0% $ 0 | |
| Independent Director | less than a year | no data | 0% $ 0 | |
| Member of Scientific Advisory Board | 1.4yrs | no data | no data | |
| Scientific & Clinical Advisor | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 1.4yrs | no data | no data | |
| Independent Director | less than a year | no data | 0% $ 0 | |
| Member of Scientific Advisory Board | 1.4yrs | no data | no data |
0.9yrs
Average Tenure
58yo
Average Age
Experienced Board: NKGN's board of directors are not considered experienced ( 0.9 years average tenure), which suggests a new board.